Taking buprenorphine, naloxone produces ‘unintended positive’ effect in patients with diabetes

Patients with diabetes who were managing opioid addiction with buprenorphine-naloxone substitution therapy had decreases in their glycated HbA1c values, according to findings recently published in Canadian Family Physician. “Both opioid use disorders and [type 2 diabetes mellitus] are chronic medical illnesses in which noncompliance with treatment is a common problem influenced by psychosocial factors,” Devon Tilbrook, MD, CCFP, a physician practicing in Sioux Lookout, Ontario, Canada, and colleagues wrote. “Different treatment methods for opioid use disorders have varying effects on diabetes control.”Original Article